Rafferty Asset Management’s Beam Therapeutics BEAM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.09M | Buy |
122,832
+2,961
| +2% | +$50.4K | 0.01% | 597 |
|
|
2025
Q1 | $2.34M | Buy |
119,871
+8,771
| +8% | +$171K | 0.01% | 533 |
|
|
2024
Q4 | $2.76M | Sell |
111,100
-75,991
| -41% | -$1.88M | 0.01% | 552 |
|
|
2024
Q3 | $4.58M | Buy |
187,091
+21,827
| +13% | +$535K | 0.02% | 441 |
|
|
2024
Q2 | $3.87M | Sell |
165,264
-79,090
| -32% | -$1.85M | 0.01% | 474 |
|
|
2024
Q1 | $8.07M | Sell |
244,354
-95,363
| -28% | -$3.15M | 0.03% | 343 |
|
|
2023
Q4 | $9.25M | Sell |
339,717
-424
| -0.1% | -$11.5K | 0.04% | 302 |
|
|
2023
Q3 | $8.18M | Buy |
340,141
+82,150
| +32% | +$1.98M | 0.05% | 279 |
|
|
2023
Q2 | $8.24M | Buy |
257,991
+46,323
| +22% | +$1.48M | 0.05% | 261 |
|
|
2023
Q1 | $6.48M | Buy |
211,668
+16,943
| +9% | +$519K | 0.04% | 317 |
|
|
2022
Q4 | $7.62M | Buy |
194,725
+70,800
| +57% | +$2.77M | 0.06% | 275 |
|
|
2022
Q3 | $5.9M | Buy |
123,925
+2,952
| +2% | +$141K | 0.06% | 297 |
|
|
2022
Q2 | $4.68M | Buy |
120,973
+30,590
| +34% | +$1.18M | 0.04% | 286 |
|
|
2022
Q1 | $5.18M | Buy |
90,383
+16,604
| +23% | +$951K | 0.03% | 384 |
|
|
2021
Q4 | $5.88M | Buy |
73,779
+45,173
| +158% | +$3.6M | 0.03% | 312 |
|
|
2021
Q3 | $2.49M | Sell |
28,606
-784
| -3% | -$68.2K | 0.02% | 565 |
|
|
2021
Q2 | $3.78M | Sell |
29,390
-4,464
| -13% | -$575K | 0.02% | 425 |
|
|
2021
Q1 | $2.71M | Buy |
33,854
+23,029
| +213% | +$1.84M | 0.02% | 545 |
|
|
2020
Q4 | $884K | Buy |
+10,825
| New | +$884K | 0.01% | 535 |
|